Academic literature review

• Minnen, L. M. van der; Grooten, I.J.; Dean, C. et al. (2025). The impact and management of hyperemesis gravidarum: Current and future perspectives. (external link)
• Fejzo, Marlena Schoenberg; Trovik, Jone; Grooten, Iris J. et al. (2019). Nausea and vomiting of pregnancy and hyperemesis gravidarum. (external link)
• Salvesen, Helga Birgitte; Haldorsen, Ingfrid S.; Trovik, Jone (2012). Markers for individualised therapy in endometrial carcinoma. (external link)

Academic article

• Sharami, Alexander Nima; Feiring, Mari Heide; Eide, Ellen Nydal et al. (2025). Long-term patient-reported outcome for surgical management of pelvic organ prolapse: A retrospective cohort study. (external link)
• Lura, Njål; Wagner-Larsen, Kari Strøno; Ryste, Stian Torkildson et al. (2025). Tumor ADC value predicts outcome and yields refined prognostication in uterine cervical cancer. (external link)
• Berg, Hege Fredriksen; Trovik, Jone; Hjelmeland, Marta Espevold et al. (2025). Pragmatic preoperative molecular classification of endometrial cancers; Replacing POLE sequencing with hormone receptor staining. (external link)
• Meijs-Hermanns, Puk; Werner, Henrica Maria Johanna; Kooreman, Loes et al. (2025). Improving pre-operative binary grading: relevance of p53 and PR expression in grade 2 endometrioid endometrial carcinoma. (external link)
• Hjelmeland, Marta Espevold; Lien, Hilde Eide; Berg, Hege Fredriksen et al. (2024). Loss of vimentin expression in preoperative biopsies independently predicts poor prognosis, lymph node metastasis and recurrence in endometrial cancer. (external link)
• Erdal, Hilde; Holst, Lone; Heitmann, Kristine et al. (2024). Guidelines for Treatment of Hyperemesis Gravidarum and Implementation in Clinical Practice in Norway: A Descriptive Study. (external link)
• Berg, Madeleine Charlotte van der; Berg, Hege Fredriksen; Stokowy, Tomasz et al. (2024). Expression patterns of mismatch repair proteins in cervical cancer uncover independent prognostic value of MSH-2. (external link)
• Lien, Hilde Eide; Berg, Hege Fredriksen; Halle, Mari Kyllesø et al. (2023). Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent disease. (external link)
• Berg, Hege Fredriksen; Engerud, Hilde Renate; Myrvold, Madeleine et al. (2022). Mismatch repair markers in preoperative and operative endometrial cancer samples; expression concordance and prognostic value. (external link)
• Wagner-Larsen, Kari Strøno; Lura, Njål Gjærde; Salvesen, Øyvind et al. (2022). Interobserver agreement and prognostic impact for MRI–based 2018 FIGO staging parameters in uterine cervical cancer. (external link)
• Lura, Njål Gjærde; Wagner-Larsen, Kari Strøno; Forsse, David Erik et al. (2022). What MRI-based tumor size measurement is best for predicting long-term survival in uterine cervical cancer?. (external link)
• Dybvik, Julie Andrea; Fasmer, Kristine Eldevik; Ytre-Hauge, Sigmund et al. (2022). MRI-assessed tumor-free distance to serosa predicts deep myometrial invasion and poor outcome in endometrial cancer. (external link)
• Erdal, Hilde; Holst, Lone; Heitmann, Kristine et al. (2022). Antiemetic treatment of hyperemesis gravidarum in 1,064 Norwegian women and the impact of European warning on metoclopramide: a retrospective cohort study 2002–2019. (external link)
• Fasmer, Kristine Eldevik; Gulati, Ankush; Dybvik, Julie Andrea et al. (2022). Preoperative pelvic MRI and 2-[18F]FDG PET/CT for lymph node staging and prognostication in endometrial cancer—time to revisit current imaging guidelines?. (external link)
• Lindemann, Kristina Yvonne Kathe; Smogeli, Aud Elisabeth Farstad; Småstuen, Milada Cvancarova et al. (2021). Salvage radiation for pelvic relapse after surgically treated endometrial cancer. (external link)
• Fonnes, Tina; Telle, Ingrid Ovidia Moe; Forsse, David Erik et al. (2021). Cancer awareness in the general population varies with sex, age and media coverage: A population-based survey with focus on gynecologic cancers. (external link)
• Forsse, David Erik; Barbero, Mark Lewis B Barbero; Werner, Henrica Maria Johanna et al. (2021). Longitudinal effects of adjuvant chemotherapy and lymph node staging on patient-reported outcomes in endometrial cancer survivors: a prospective cohort study. (external link)
• Halle, Mari Kyllesø; Sødal, Marte; Forsse, David Erik et al. (2021). A 10-gene prognostic signature points to LIMCH1 and HLA-DQB1 as important players in aggressive cervical cancer disease. (external link)
• Vrede, S.W.; Weelden, Willem Jan van; Visser, Nicole C.M. et al. (2021). Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer. (external link)
• Dean, Caitlin R; Bierma, Hyke; Clarke, Ria et al. (2021). A patient-clinician James Lind Alliance partnership to identify research priorities for hyperemesis gravidarum. (external link)
• Pedersen, Judith Krossøy; Sira, Cecilie; Trovik, Jone (2021). Handheld transabdominal ultrasound, after limited training, may confirm first trimester viable intrauterine pregnancy: a prospective cohort study. (external link)
• Jacob, Havjin; Dybvik, Julie Andrea; Ytre-Hauge, Sigmund et al. (2021). An mri-based radiomic prognostic index predicts poor outcome and specific genetic alterations in endometrial cancer. (external link)
• Berg, Hege Fredriksen; Hjelmeland, Marta Espevold; Lien, Hilde Eide et al. (2021). Patient-derived organoids reflect the genetic profile of endometrial tumors and predict patient prognosis. (external link)
• Engerud, Hilde Renate; Berg, Hege Fredriksen; Myrvold, Madeleine et al. (2020). High degree of heterogeneity of PD-L1 and PD-1 from primary to metastatic endometrial cancer. (external link)
• Berg, Hege Fredriksen; Ju, Zhenlin; Myrvold, Madeleine et al. (2020). Development of prediction models for lymph node metastasis in endometrioid endometrial carcinoma. (external link)
• Fasmer, Kristine Eldevik; Gulati, Ankush; Dybvik, Julie Andrea et al. (2020). Preoperative 18F-FDG PET/CT tumor markers outperform MRI-based markers for the prediction of lymph node metastases in primary endometrial cancer. (external link)
• Reijnen, Casper; Gogou, Evangelia; Visser, Nicole C.M. et al. (2020). Preoperative risk stratification in endometrial cancer (ENDORISK) by a Bayesian network model: A development and validation study. (external link)
• Ytre-Hauge, Sigmund; Salvesen, Øyvind; Krakstad, Camilla et al. (2020). Tumour texture features from preoperative CT predict high-risk disease in endometrial cancer. (external link)
• Virdee, Navneet Kaur; Ringdal, Emilie Kallåk; Thornhill, Heidi Frances et al. (2020). Gynekologiske fistler etter kirurgi og strålebehandling. (external link)
• Forsse, David Erik; Berg, Hege Fredriksen; Bozickovic, Olivera et al. (2020). Maintained survival outcome after reducing lymphadenectomy rates and optimizing adjuvant treatment in endometrial cancer. (external link)
• Fasmer, Kristine Eldevik; Hodneland, Erlend; Dybvik, Julie Andrea et al. (2020). Whole-volume tumor MRI radiomics for prognostic modeling in endometrial cancer. (external link)
• Kleppe, Andreas; Albregtsen, Fritz; Trovik, Jone et al. (2020). Prognostic value of the diversity of nuclear chromatin compartments in gynaecological carcinomas. (external link)
• Meinich, Tale Jeanette; Trovik, Jone (2020). Early maternal weight gain as a risk factor for SGA in pregnancies with hyperemesis gravidarum: A 15-year hospital cohort study. (external link)
• Helleland, Liva; Bergesen, Lena Flekke; Rinnan, Karen Jakobsen et al. (2019). Endometrial ablation; Less is more? Historical cohort study comparing long-term outcomes from two time periods and two treatment modalities for 854 women. (external link)
• Holst, Frederik; Werner, Henrica Maria Johanna; Mjøs, Siv et al. (2019). PIK3CA amplification associates with aggressive phenotype but not markers of AKT-mTOR signaling in endometrial carcinoma. (external link)
• Forsse, David Erik; Tangen, Ingvild Løberg; Fasmer, Kristine Eldevik et al. (2019). Blood steroid levels predict survival in endometrial cancer and reflect tumor estrogen signaling. (external link)
• Reijnen, Casper; Weelden, Willem Jan van; Arts, Martijn S.J.P. et al. (2019). Poor outcome in hypoxic endometrial carcinoma is related to vascular density. (external link)
• Changole, Josephine; Thorsen, Viva Combs; Trovik, Jone et al. (2019). Coping with a disruptive life caused by obstetric fistula: Perspectives from Malawian women. (external link)
• Strand, Elin; Tangen, Ingvild Løberg; Fasmer, Kristine Eldevik et al. (2019). Blood metabolites associate with prognosis in endometrial cancer. (external link)
• Visser, Nicole C.M.; Putten, Louis J.M. van der; Egerschot, Alex van et al. (2019). Addition of IMP3 to L1CAM for discrimination between low- and high-grade endometrial carcinomas: a European Network for Individualised Treatment of Endometrial Cancer collaboration study. (external link)
• Zhao, Y.; Yang, Y.; Trovik, Jone et al. (2019). Novel PCDH10-Wnt-MALAT1 regulatory axis in endometrioid endometrial adenocarcinoma. (external link)
• Engerud, Hilde Renate; Hope, Kirsten Øvergaard; Berg, Hege Fredriksen et al. (2019). Plasma growth differentiation factor-15 is an independent marker for aggressive disease in endometrial cancer. (external link)
• Børseth, Katrine Trovik Flaatten; Acharya, Ganesh; Kiserud, Torvid et al. (2019). Incidence of gynecological fistula and its surgical treatment: A national registry-based study. (external link)
• Versluis, Mac; Plat, Annechien; Bruyn, Marco de et al. (2018). L1CAM expression in uterine carcinosarcoma is limited to the epithelial component and may be involved in epithelial-mesenchymal transition. (external link)
• Kusonmano, Kanthida; Halle, Mari Kyllesø; Wik, Elisabeth et al. (2018). Identification of highly connected and differentially expressed gene subnetworks in metastasizing endometrial cancer. (external link)
• Bollineni, Vikram Rao; Ytre-Hauge, Sigmund; Gulati, Ankush et al. (2018). The prognostic value of preoperative FDG-PET/CT metabolic parameters in cervical cancer patients. (external link)
• Nielsen, Birgitte; Kleppe, Andreas; Hveem, Tarjei Sveinsgjerd et al. (2018). Association Between Proportion of Nuclei With High Chromatin Entropy and Prognosis in Gynecological Cancers. (external link)
• Tangen, Ingvild Løberg; Fasmer, Kristine Eldevik; Konings, Gonda F et al. (2018). Blood steroids are associated with prognosis and fat distribution in endometrial cancer. (external link)
• Putten, Louis J.M. Van Der; Visser, Nicole C.M.; Vijver, Koen Van De et al. (2018). Added value of estrogen receptor, progesterone receptor, and L1 cell adhesion molecule expression to histology-based endometrial carcinoma recurrence prediction models: An ENITEC Collaboration study. (external link)
• Kleppe, Andreas; Albregtsen, Fritz; Vlatkovic, Ljiljana et al. (2018). Chromatin organisation and cancer prognosis: a pan-cancer study. (external link)
• Bischof, Katharina; Knappskog, Stian; Stefansson, Ingunn et al. (2018). High expression of the p53 isoform ? is associated with reduced progression-free survival in uterine serous carcinoma. (external link)
• Painter, Jodie N.; O'Mara, Tracy A.; Morris, Andrew P. et al. (2018). Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses. (external link)
• Fasmer, Kristine Eldevik; Bjørnerud, Atle; Ytre-Hauge, Sigmund et al. (2018). Preoperative quantitative dynamic contrast-enhanced MRI and diffusion-weighted imaging predict aggressive disease in endometrial cancer. (external link)
• O'Mara, Tracy A.; Glubb, Dylan M.; Amant, Frédéric et al. (2018). Identification of nine new susceptibility loci for endometrial cancer. (external link)
• Fonnes, Tina; Trovik, Jone; Edqvist, Per-Henrik D. et al. (2018). Asparaginase-like protein 1 expression in curettage independently predicts lymph node metastasis in endometrial carcinoma: a multicentre study. (external link)
• Ytre-Hauge, Sigmund; Dybvik, Julie Andrea; Lundervold, Arvid et al. (2018). Preoperative tumor texture analysis on MRI predicts high-risk disease and reduced survival in endometrial cancer. (external link)
• Halle, Mari Kyllesø; Ojesina, Akinyemi I; Engerud, Hilde Renate et al. (2017). Clinicopathologic and molecular markers in cervical carcinoma: a prospective cohort study. (external link)
• Mauland, Karen Klepsland; Ju, Zhenlin; Tangen, Ingvild Løberg et al. (2017). Proteomic profiling of endometrioid endometrial cancer reveals differential expression of hormone receptors and MAPK signaling proteins in obese versus non-obese patients. (external link)
• Cuppens, Tine; Annibali, Daniela; Coosemans, An et al. (2017). Potential targets' analysis reveals dual PI3K/mTOR pathway inhibition as a promising therapeutic strategy for uterine leiomyosarcomas - An ENITEC group initiative. (external link)
• Halle, Mari Kyllesø; Tangen, Ingvild Løberg; Berg, Hege Fredriksen et al. (2017). HER2 expression patterns in paired primary and metastatic endometrial cancer lesions. (external link)
• Fonnes, Tina; Berg, Hege Fredriksen; Onyango, Therese Bredholt et al. (2017). Asparaginase-like protein 1 is an independent prognostic marker in primary endometrial cancer, and is frequently lost in metastatic lesions. (external link)
• Eritja, Nuria; Jove, Mariona; Fasmer, Kristine Eldevik et al. (2017). Tumour-microenvironmental blood flow determines a metabolomic signature identifying lysophospholipids and resolvin D as biomarkers in endometrial cancer patients. (external link)
• Berg, Anna; Gulati, Ankush; Ytre-Hauge, Sigmund et al. (2017). Preoperative imaging markers and PDZ-binding kinase tissue expression predict low-risk disease in endometrial hyperplasias and low grade cancers. (external link)
• Visser, Nicole C.M.; Werner, Henrica Maria Johanna; Krakstad, Camilla et al. (2017). Type of vascular invasion in association with progress of endometrial cancer. (external link)
• Yang, Xueying; Wang, Chi Chiu; Lee, Wayne Yuk Wai et al. (2017). Long non-coding RNA HAND2-AS1 inhibits invasion and metastasis in endometrioid endometrial carcinoma through inactivating neuromedin U. (external link)
• Tangen, Ingvild Løberg; Kopperud, Reidun Kristin; Visser, Nicole C.M. et al. (2017). Expression of L1CAM in curettage or high L1CAM level in preoperative blood samples predicts lymph node metastases and poor outcome in endometrial cancer patients. (external link)
• Ytre-Hauge, Sigmund; Esmaeili, Morteza; Sjøbakk, Torill Eidhammer et al. (2017). In vivo MR spectroscopy predicts high tumor grade in endometrial cancer. (external link)
• Tangen, Ingvild Løberg; Venereis, Jennifer Taylor; Halle, Mari Kyllesø et al. (2017). Expression of glucocorticoid receptor is associated with aggressive primary endometrial cancer and increases from primary to metastatic lesions. (external link)
• Mauland, Karen Klepsland; Eng, Øyvin Andre Solberg; Ytre-Hauge, Sigmund et al. (2017). High visceral fat percentage is associated with poor outcome in endometrial cancer. (external link)
• Njølstad, Tormund Salvesen; Werner, Henrica Maria Johanna; Marcickiewicz, Janusz et al. (2017). Late-week surgical treatment of endometrial cancer is associated with worse long-term outcome: Results from a prospective, multicenter study. (external link)
• Mjøs, Siv; Werner, Henrica Maria Johanna; Birkeland, Even et al. (2017). PIK3CA exon9 mutations associate with reduced survival, and are highly concordant between matching primary tumors and metastases in endometrial cancer. (external link)
• Thompson, Deborah J.; O'Mara, Tracy A.; Glubb, Dylan M. et al. (2016). CYP19A1 fine-mapping and Mendelian randomization: Estradiol is causal for endometrial cancer. (external link)
• Painter, Jodie N.; O'Mara, Tracy A.; Marquart, Louise et al. (2016). Genetic risk score mendelian randomization shows that obesity measured as body mass index, but not waist:hip ratio, is causal for endometrial cancer. (external link)
• Gibson, William J.; Høivik, Erling Andre; Halle, Mari Kyllesø et al. (2016). The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis. (external link)
• Tangen, Ingvild Løberg; Onyango, Therese Bredholt; Kopperud, Reidun Kristin et al. (2016). Androgen receptor as potential therapeutic target in metastatic endometrial cancer. (external link)
• Hveem, Tarjei Sveinsgjerd; Njølstad, Tormund Salvesen; Nielsen, Birgitte et al. (2016). Changes in Chromatin Structure in Curettage Specimens Identifies High-Risk Patients in Endometrial Cancer. (external link)
• Mauland, Karen Klepsland; Wik, Elisabeth; Høivik, Erling Andre et al. (2016). Aneuploidy related transcriptional changes in endometrial cancer link low expression of chromosome 15q genes to poor survival. (external link)
• Yang, Ji-Yeon; Werner, Henrica Maria Johanna; Li, Jie et al. (2016). Integrative protein-based prognostic model for early-stage endometrioid endometrial cancer. (external link)
• Cheng, Timothy H.T.; Thompson, Deborah J.; O'Mara, Tracy A. et al. (2016). Five endometrial cancer risk loci identified through genome-wide association analysis. (external link)
• Putten, Louis J.M. Van Der; Visser, Nicole C.M.; Vijver, Koen Van de et al. (2016). L1CAM expression in endometrial carcinomas: An ENITEC collaboration study. (external link)
• Trovik, Jone; Vikanes, Åse Vigdis (2016). Hyperemesis Gravidarum is associated with substantial economic burden in addition to severe physical and psychological suffering. (external link)
• Trovik, Jone; Thornhill, Heidi Frances; Kiserud, Torvid (2016). Incidence of obstetric fistula in Norway: A population-based prospective cohort study. (external link)
• Holst, Frederik; Høivik, Erling Andre; Gibson, William J. et al. (2016). Recurrent hormone-binding domain truncated ESR1 amplifications in primary endometrial cancers suggest their implication in hormone independent growth. (external link)
• Berg, Anna; Fasmer, Kristine Eldevik; Mauland, Karen Klepsland et al. (2016). Tissue and imaging biomarkers for hypoxia predict poor outcome in endometrial cancer. (external link)
• Painter, Jodie N.; O'Mara, Tracy A.; Batra, Jyotsna et al. (2015). Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk. (external link)
• Ytre-Hauge, Sigmund; Husby, Jenny Hild Aase; Magnussen, Inger Johanne et al. (2015). Preoperative tumor size at MRI predicts deep myometrial invasion, lymph node metastases, and patient outcome in endometrial carcinomas. (external link)
• Carvajal-Carmona, Luis G.; O'Mara, Tracy A.; Painter, Jodie N. et al. (2015). Candidate locus analysis of the TERT–CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk. (external link)
• Birkeland, Elisabeth Sofie; Stokke, Guro; Tangvik, Randi Julie et al. (2015). Norwegian PUQE (pregnancy-unique quantification of emesis and nausea) identifies patients with hyperemesis gravidarum and poor nutritional intake: A prospective cohort validation study. (external link)
• Cheng, Timothy H.T.; Thompson, Deborah; Painter, Jodie et al. (2015). Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1. (external link)
• Stefansson, Ingunn; Ræder, Maria B; Wik, Elisabeth et al. (2015). Increased angiogenesis is associated with a 32-gene expression signature and 6p21 amplification in aggressive endometrial cancer. (external link)
• Berg, Anna; Høivik, Erling Andre; Mjøs, Siv et al. (2015). Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients. (external link)
• Bredholt, Geir; Mannelqvist, Monica; Stefansson, Ingunn et al. (2015). Tumor necrosis is an important hallmark of aggressive endometrial cancer and associates with hypoxia, angiogenesis and inflammation responses. (external link)
• Krakstad, Camilla; Tangen, Ingvild Løberg; Høivik, Erling Andre et al. (2015). ATAD2 overexpression links to enrichment of B-MYBtranslational signatures and development of aggressive endometrial carcinoma. (external link)
• O'Mara, Tracy A.; Glubb, Dylan M.; Painter, Jodie N. et al. (2015). Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer. (external link)
• Stokke, Guro; Gjelsvik, Bente Leirvåg; Flaatten, Katrine Trovik et al. (2015). Hyperemesis gravidarum, nutritional treatment by nasogastric tube feeding: A 10-year retrospective cohort study. (external link)
• Husby, Jenny Hild Aase; Salvesen, Øyvind; Magnussen, Inger Johanne et al. (2015). Tumour apparent diffusion coefficient is associated with depth of myometrial invasion and is negatively correlated to tumour volume in endometrial carcinomas. (external link)
• Njølstad, Tormund Salvesen; Trovik, Jone; Hveem, Tarjei Sveinsgjerd et al. (2015). DNA ploidy in curettage specimens identifies high-risk patients and lymph node metastasis in endometrial cancer. (external link)
• Husby, Jenny Hild Aase; Reitan, Bernt Christian; Biermann, Martin et al. (2015). Metabolic tumor volume on 18F-FDG PET/CT improves preoperative identification of high-risk endometrial carcinoma patients. (external link)
• Mackay, Helen; Eisenhauer, Elizabeth A.; Kamel-Reid, Suzanne et al. (2014). Molecular determinants of outcome with mammalian target of rapamycin inhibition in endometrial cancer. (external link)
• Haldorsen, Ingfrid S.; Stefansson, Ingunn; Grüner, Renate et al. (2014). Increased microvascular proliferation is negatively correlated to tumour blood flow and is associated with unfavourable outcome in endometrial carcinomas. (external link)
• Carvajal-Carmona, Luis G.; O'Mara, Tracy A; Painter, Jodie N et al. (2014). Candidate locus analysis of the TERT–CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk. (external link)
• Høivik, Erling Andre; Kusonmano, Kanthida; Halle, Mari Kyllesø et al. (2014). Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene. (external link)
• Werner, Henrica Maria Johanna; Trovik, Jone; Halle, Mari Kyllesø et al. (2014). Stathmin Protein Level, a Potential Peredictive Marker for Taxane Treatment Response in Endometrial Cancer. (external link)
• Tangen, Ingvild Løberg; Werner, Henrica Maria Johanna; Berg, Anna et al. (2014). Loss of progesterone receptor links to high proliferation and increases from primary to metastatic endometrial cancer lesions. (external link)
• Zhao, Yu; Yang, Yihua; Trovik, Jone et al. (2014). A novel Wnt regulatory axis in endometrioid endometrial cancer. (external link)
• Alonso-Alconada, Lorena; Muinelo-Romay, Laura; Madissoo, Kadri et al. (2014). Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer. (external link)
• Wik, Elisabeth; Trovik, Jone; Kusonmano, Kanthida et al. (2014). Endometrial Carcinoma Recurrence Score (ECARS) validates to identify aggressive disease and associates with markers of epithelial-mesenchymal transition and PI3K alterations. (external link)
• Trovik, Jone; Salvesen, Helga; Cuppens, Tine et al. (2014). Growth differentiation factor-15 as biomarker in uterine sarcomas. (external link)
• Engerud, Hilde Renate Haugen; Tangen, Ingvild Løberg; Berg, Ansgar et al. (2014). High level of HSF1 associates with aggressive endometrial carcinoma and suggests potential for HSP90 inhibitors. (external link)
• Tangen, Ingvild Løberg; Krakstad, Camilla; Halle, Mari Kyllesø et al. (2014). Switch in FOXA1 status associates with endometrial cancer progression. (external link)
• Njølstad, Tormund Salvesen; Engerud, Hilde Renate H; Werner, Henrica Maria Johanna et al. (2013). Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas. (external link)
• Werner, Henrica Maria Johanna; Berg, Anna; Wik, Elisabeth et al. (2013). ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas. (external link)
• Werner, Henrica Maria Johanna; Trovik, Jone; Marcickiewicz, Janusz et al. (2013). A discordant histological risk classification in preoperative and operative biopsy in endometrial cancer is reflected in metastatic risk and prognosis. (external link)
• Haldorsen, Ingfrid S.; Grüner, Renate; Husby, Jenny Hild Aase et al. (2013). Dynamic contrast-enhanced MRI in endometrial carcinoma identifies patients at increased risk of recurrence. (external link)
• Wik, Elisabeth; Birkeland, Even; Trovik, Jone et al. (2013). High phospho-stathmin(Serine38) expression identifies aggressive endometrial cancer and suggests an association with PI3K inhibition. (external link)
• Wik, Elisabeth; Ræder, Maria B; Krakstad, Camilla et al. (2013). Lack of estrogen receptor-alpha is associated with epithelial-mesenchymal transition and PI3K alterations in endometrial carcinoma. (external link)
• Trovik, Jone; Wik, Elisabeth; Werner, Henrica Maria Johanna et al. (2013). Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial. (external link)
• Ræder, Maria B; Birkeland, Even; Trovik, Jone et al. (2013). Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers. (external link)
• Delahanty, Ryan J.; Xiang, Yong-Bing; Spurdle, Amanda et al. (2013). Polymorphisms in inflammation pathway genes and endometrial cancer risk. (external link)
• Krakstad, Camilla; Trovik, Jone; Wik, Elisabeth et al. (2012). Loss of GPER identifies new targets for therapy among a subgroup of ER alpha-positive endometrial cancer patients with poor outcome. (external link)
• Krakstad, Camilla; Birkeland, Even; Seidel, Danila et al. (2012). High-throughput mutation profiling of primary and metastatic endometrial cancers identifies KRAS, FGFR2 and PIK3CA to be frequently mutated. (external link)
• Werner, Henrica Maria Johanna; Trovik, Jone; Marcickiewicz, Janusz et al. (2012). Revision of FIGO surgical staging in 2009 for endometrial cancer validates to improve risk stratification. (external link)
• Birkeland, Even; Wik, Elisabeth; Mjøs, Siv et al. (2012). KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer. (external link)
• Knappskog, Stian; Gansmo, Liv Beathe; Romundstad, Pål Richard et al. (2012). MDM2 Promoter SNP344T>A (rs1196333) Status Does Not Affect Cancer Risk. (external link)
• Haldorsen, Ingfrid S.; Husby, Jenny Hild Aase; Werner, Henrica Maria Johanna et al. (2012). Standard 1.5-T MRI of endometrial carcinomas: modest agreement between radiologists. (external link)
• Knappskog, Stian; Trovik, Jone; Marcickiewicz, Janusz et al. (2012). SNP285C modulates oestrogen receptor/Sp1 binding to the MDM2 promoter and reduces the risk of endometrial but not prostatic cancer. (external link)
• Long, Jirong; Zheng, Wei; Xiang, Yong-Bing et al. (2012). Genome-wide association study identifies a possible susceptibility locus for endometrial cancer. (external link)
• Trovik, Jone; Mauland, Karen Klepsland; Werner, Henrica Maria Johanna et al. (2012). Improved survival related to changes in endometrial cancer treatment, a 30-year population based perspective. (external link)
• Haldorsen, Ingfrid S.; Berg, Anna; Werner, Henrica Maria Johanna et al. (2012). Magnetic resonance imaging performs better than endocervical curettage for preoperative prediction of cervical stromal invasion in endometrial carcinomas. (external link)
• Spurdle, Amanda B; Ahmed, Shahana; Ferguson, Kaltin et al. (2011). Genome-wide association study identifies a common variant associated with risk of endometrial cancer. (external link)
• Staff, Anne Cathrine; Trovik, Jone; Eriksson, Ane Gerda Zahl et al. (2011). Elevated plasma growth differentiation factor-15 correlates with lymph node metastases and poor survival in endometrial cancer. (external link)
• Mauland, Karen Klepsland; Trovik, Jone; Wik, Elisabeth et al. (2011). High BMI is significantly associated with positive progesterone receptor status and clinico-pathological markers for non-aggressive disease in endometrial cancer. (external link)
• Vandenput, Ingrid; Trovik, Jone; Vergote, Ignace et al. (2011). The role of adjuvant chemotherapy in surgical stages I-II serous and clear cell carcinomas and carcinosarcoma of the endometrium a collaborative study. (external link)
• Vandenput, Ingrid; Trovik, Jone; Leunen, Karin et al. (2011). Evolution in endometrial cancer evidence from an immunohistochemical study. (external link)
• Trovik, Jone; Wik, Elisabeth; Stefansson, Ingunn Marie et al. (2011). Stathmin Overexpression Identifies High-Risk Patients and Lymph Node Metastasis in Endometrial Cancer. (external link)
• Bhriain, Hannah Ni; Trovik, Jone; Wik, Elisabeth et al. (2009). Plasma calprotectin concentrations in women with endometrial carcinoma. (external link)
• Wik, Elisabeth; Trovik, Jone; Iversen, Ole-Erik et al. (2009). Deoxyribonucleic acid ploidy in endometrial carcinoma: a reproducible and valid prognostic marker in a routine diagnostic setting. (external link)
• Salvesen, Helga Birgitte; Carter, Scott L.; Mannelqvist, Monica et al. (2009). Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation. (external link)
• Dutt, Amit; Salvesen, Helga; Chent, Tzu-Hsiu et al. (2008). Drug-sensitive FGFR2 mutations in endometrial carcinoma. (external link)
• Egeland, Philip; Gjøen, John Espen; Trovik, Jone et al. (2007). Gynekologiske fistler til urinveier og tarm. (external link)

Errata

• Lien, Hilde Eide; Berg, Hege Fredriksen; Halle, Mari Kyllesø et al. (2023). Corrigendum to “Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent disease” [EBioMedicine 92 (2023) 104595] (eBioMedicine (2023) 92, (S2352396423001603), (10.1016/j.ebiom.2023.104595)). (external link)
• Berg, Hege Fredriksen; Hjelmeland, Marta Espevold; Lien, Hilde Eide et al. (2021). Author Correction: Patient-derived organoids reflect the genetic profile of endometrial tumors and predict patient prognosis (Communications Medicine, (2021), 1, 1, (20), 10.1038/s43856-021-00019-x). (external link)
• Meinich, Tale Jeanette; Trovik, Jone (2020). Erratum: Early maternal weight gain as a risk factor for SGA in pregnancies with hyperemesis gravidarum: A 15-year hospital cohort study (BMC Pregnancy and Childbirth (2020) 20:255 DOI: 10.1186/s12884-020-02947-3). (external link)

Textbook

• Knudsen, Ulla Breth; Gemzell-Danielsson, Kristina; Trovik, Jone et al. (2020). Obstetrics and Gynecology. NFOG textbook for medical students. (external link)

Academic lecture

• Holst, Lone; Heitmann, Kristine; Kristiansen, Cathrine Helgestad et al. (2019). European antiemetic regulations (restricting metoclopramide use) increases admission rates due to hyperemesis gravidarum.. (external link)
• Ytre-Hauge, Sigmund; Hanson, E; Lundervold, Arvid et al. (2015). Preoperative tumor texture at MRI predicts deep myometrial invasion and non-endometrioid subtype in endometrial carcinomas. (external link)

Poster

• Nilsen, Charlotte; Lunestad, Mona; Engelsen, Ingeborg Bøe et al. (2015). Nasogastric feeding in hyperemesis gravidarum; tube positioning by ward nurse, a pilot study. (external link)
• Husby, Jenny Hild Aase; Reitan, Bernt; Trovik, Jone et al. (2014). Metabolic tumor volume on FDG-PET/CT predicts deep myometrial invasion, lymph node metastases and survival in patients with endometrial carcinoma. (external link)
• Trovik, Jone; Wik, Elisabeth; Stefansson, Ingunn Marie et al. (2009). Stathmin is superior to AKT and Phospho-AKT staining to detect PI3Kinase activation and aggressive endometrial cancer. (external link)

Reader opinion piece

• Trovik, Jone; Vikanes, Åse Vigdis (2015). Kvantifisering av svangerskapskvalme :. (external link)
• Trovik, Jone (2014). Ikke "bare" svangerskapskvalme. (external link)
• Halle, Mari Kyllesø; Werner, Henrica Maria Johanna; Krakstad, Camilla et al. (2012). Stratification based on high tumour cell content in fresh frozen tissue promotes selection of aggressive endometrial carcinomas. (external link)
• Trovik, Jone; Wik, Elisabeth; Stefansson, Ingunn Marie et al. (2010). Stathmin is superior to AKT and phospho-AKT staining for the detection of phosphoinositide 3-kinase activation and aggressive endometrial cancer. (external link)

Interview

• Sørbye, Sveinung Wergeland; Stålcrantz, Jeanette; Trovik, Jone et al. (2014). - Alle kvinner bør ta denne vaksinen. (external link)

Doctoral dissertation

• Trovik, Jone (2012). Endometrial carcinoma; can biomarkers aid in the prediction of aggressive disease? A study with focus on preoperative tumour markers. (external link)

See a complete overview of publications in Cristin.